Quantitative  	Quantitative  	 JJ	B-NP
mass  	mass  	 NN	I-NP
spectrometric  	spectrometric  	 NN	I-NP
immunoassay  	immunoassay  	 NN	I-NP
for  	for  	 IN	I-NP
the  	the  	 DT	I-NP
chemokine  	chemokine  	 JJ	I-NP
RANTES  	RANTES  	 NNP	I-NP
and  	and  	 CC	O
its  	its  	 PRP$	O
variants  	variants  	 NNS	O
The  	The  	 DT	O
chemokine  	chemokine  	 JJ	B-NP
RANTES  	RANTES  	 NNP	I-NP
plays  	plays  	 VBZ	O
a  	a  	 DT	O
key  	key  	 JJ	B-NP
role  	role  	 NN	I-NP
in  	in  	 IN	O
inflammation 	inflammation 	 NN	B-NP
,  	,  	 ,	O
cell  	cell  	 NN	O
recruitment  	recruitment  	 NN	O
and  	and  	 CC	O
T  	T  	 NN	B-NP
cell  	cell  	 NN	I-NP
activation 	activation 	 NN	I-NP
.  	.  	 .	O
RANTES  	RANTES  	 NNP	B-NP
is  	is  	 VBZ	O
heterogenic  	heterogenic  	 VBN	O
and  	and  	 CC	O
exists  	exists  	 VBZ	O
as  	as  	 RB	O
multiple  	multiple  	 JJ	O
variants  	variants  	 NN	O
in  	in  	 IN	O
vivo 	vivo 	 NN	B-NP
.  	.  	 .	O
Herein  	Herein  	 VBG	O
we  	we  	 PRP	O
describe  	describe  	 VBP	O
the  	the  	 DT	O
development  	development  	 NN	O
and  	and  	 CC	O
characterization  	characterization  	 NN	B-NP
of  	of  	 IN	O
a  	a  	 DT	O
fully  	fully  	 RB	O
quantitative  	quantitative  	 JJ	B-NP
mass  	mass  	 NN	I-NP
spectrometric  	spectrometric  	 NN	I-NP
immunoassay  	immunoassay  	 NNS	I-NP
( 	( 	 -LRB-	O
MSIA 	MSIA 	 NNP	B-NP
)  	)  	 -RRB-	O
for  	for  	 IN	O
analysis  	analysis  	 NN	O
of  	of  	 IN	O
intact  	intact  	 JJ	O
RANTES  	RANTES  	 NNP	B-NP
and  	and  	 CC	O
its  	its  	 PRP$	O
proteoforms  	proteoforms  	 NN	B-NP
in  	in  	 IN	O
human  	human  	 JJ	O
serum  	serum  	 NN	B-NP
and  	and  	 CC	O
plasma  	plasma  	 JJ	O
samples 	samples 	 NNS	O
.  	.  	 .	O
The  	The  	 DT	O
assay  	assay  	 NN	B-NP
exhibits  	exhibits  	 VBZ	O
linearity  	linearity  	 VBN	O
over  	over  	 IN	O
a  	a  	 DT	O
wide  	wide  	 JJ	O
concentration  	concentration  	 NN	B-NP
range  	range  	 NN	I-NP
( 	( 	 -LRB-	O
1.56-200ng 	1.56-200ng 	 NNP	O
/ 	/ 	 NNP	O
mL 	mL 	 NNP	O
) 	) 	 -RRB-	O
,  	,  	 ,	O
intra-  	intra-  	 JJ	O
and  	and  	 CC	O
inter-assay  	inter-assay  	 JJ	B-NP
precision  	precision  	 NN	I-NP
with  	with  	 IN	O
CVs  	CVs  	 JJ	O
< 	< 	 SYM	O
10 	10 	 CD	O
% 	% 	 NN	O
,  	,  	 ,	O
and  	and  	 CC	O
good  	good  	 JJ	O
linearity  	linearity  	 NN	B-NP
and  	and  	 CC	O
recovery  	recovery  	 NN	B-NP
correlations 	correlations 	 NN	I-NP
.  	.  	 .	O
The  	The  	 DT	O
assay  	assay  	 NN	B-NP
was  	was  	 VBD	O
tested  	tested  	 VBN	O
in  	in  	 IN	O
different  	different  	 JJ	O
biological  	biological  	 JJ	B-NP
matrices 	matrices 	 NN	I-NP
,  	,  	 ,	O
and  	and  	 CC	O
it  	it  	 PRP	O
was  	was  	 VBD	O
benchmarked  	benchmarked  	 VBN	O
against  	against  	 IN	O
an  	an  	 DT	O
existing  	existing  	 JJ	O
RANTES  	RANTES  	 NNP	B-NP
ELISA 	ELISA 	 NNP	I-NP
.  	.  	 .	O
The  	The  	 DT	O
new  	new  	 JJ	O
RANTES  	RANTES  	 NNP	B-NP
MSIA  	MSIA  	 NNP	I-NP
was  	was  	 VBD	O
used  	used  	 VBN	O
to  	to  	 TO	O
analyze  	analyze  	 VB	O
RANTES  	RANTES  	 NNP	B-NP
and  	and  	 CC	O
its  	its  	 PRP$	O
proteoforms  	proteoforms  	 NN	B-NP
in  	in  	 IN	O
a  	a  	 DT	O
small  	small  	 JJ	O
clinical  	clinical  	 JJ	B-NP
cohort 	cohort 	 NN	I-NP
,  	,  	 ,	O
revealing  	revealing  	 VBG	O
the  	the  	 DT	O
quantitative  	quantitative  	 JJ	B-NP
distribution  	distribution  	 NN	I-NP
and  	and  	 CC	O
frequency  	frequency  	 NN	O
of  	of  	 IN	O
the  	the  	 DT	O
native  	native  	 NN	O
and  	and  	 CC	O
truncated  	truncated  	 FW	B-NP
RANTES  	RANTES  	 FW	I-NP
proteoforms 	proteoforms 	 FW	I-NP
.  	.  	 .	O
In  	In  	 IN	O
the  	the  	 DT	O
last  	last  	 JJ	O
two  	two  	 CD	O
decades 	decades 	 NNS	O
,  	,  	 ,	O
RANTES  	RANTES  	 NNP	B-NP
has  	has  	 VBZ	O
been  	been  	 VBN	O
studied  	studied  	 VBN	O
extensively  	extensively  	 RB	O
due  	due  	 JJ	O
to  	to  	 TO	O
its  	its  	 PRP$	O
association  	association  	 NN	O
with  	with  	 IN	O
numerous  	numerous  	 JJ	B-NP
clinical  	clinical  	 JJ	I-NP
conditions 	conditions 	 NNS	I-NP
,  	,  	 ,	O
including  	including  	 VBG	O
kidney-related 	kidney-related 	 JJ	O
,  	,  	 ,	O
autoimmune 	autoimmune 	 NN	B-NP
,  	,  	 ,	O
cardiovascular 	cardiovascular 	 JJ	O
,  	,  	 ,	O
viral  	viral  	 JJ	O
and  	and  	 CC	O
metabolic  	metabolic  	 JJ	B-NP
pathologies 	pathologies 	 NN	I-NP
.  	.  	 .	O
Although  	Although  	 IN	O
a  	a  	 DT	O
single  	single  	 JJ	O
gene  	gene  	 NN	B-NP
product 	product 	 NN	I-NP
,  	,  	 ,	O
RANTES  	RANTES  	 NNP	B-NP
is  	is  	 VBZ	O
expressed  	expressed  	 VBN	O
in  	in  	 IN	O
a  	a  	 DT	O
range  	range  	 NN	O
of  	of  	 IN	O
cells  	cells  	 NNS	O
and  	and  	 CC	O
tissues  	tissues  	 NNS	O
presenting  	presenting  	 VBG	O
with  	with  	 IN	O
different  	different  	 JJ	O
endogenously  	endogenously  	 NN	O
produced  	produced  	 VBD	B-NP
variants  	variants  	 JJ	I-NP
and  	and  	 CC	O
PTMs 	PTMs 	 JJ	O
.  	.  	 .	O
The  	The  	 DT	O
structural  	structural  	 JJ	B-NP
variety  	variety  	 NN	I-NP
and  	and  	 CC	O
population  	population  	 NN	B-NP
diversity  	diversity  	 NN	I-NP
that  	that  	 WDT	O
has  	has  	 VBZ	O
been  	been  	 VBN	O
identified  	identified  	 VBN	O
for  	for  	 IN	O
RANTES  	RANTES  	 NNP	B-NP
necessitate  	necessitate  	 VBZ	O
developing  	developing  	 VBG	O
advanced  	advanced  	 JJ	O
methodologies  	methodologies  	 NNS	O
that  	that  	 WDT	O
can  	can  	 MD	O
provide  	provide  	 VB	O
insight  	insight  	 VBN	O
into  	into  	 IN	O
the  	the  	 DT	O
protein  	protein  	 NN	B-NP
heterogeneity  	heterogeneity  	 NNS	I-NP
and  	and  	 CC	O
its  	its  	 PRP$	O
function  	function  	 NN	O
and  	and  	 CC	O
regulation  	regulation  	 NN	O
in  	in  	 IN	O
disease 	disease 	 NN	O
.  	.  	 .	O
In  	In  	 IN	O
this  	this  	 DT	O
work  	work  	 NN	O
we  	we  	 PRP	O
present  	present  	 VBP	O
a  	a  	 DT	O
simple 	simple 	 JJ	O
,  	,  	 ,	O
efficient  	efficient  	 JJ	O
and  	and  	 CC	O
high-throughput  	high-throughput  	 JJ	B-NP
mass  	mass  	 NN	I-NP
spectrometric  	spectrometric  	 NN	I-NP
immunoassay  	immunoassay  	 NNS	I-NP
( 	( 	 -LRB-	O
MSIA 	MSIA 	 NNP	B-NP
)  	)  	 -RRB-	O
method  	method  	 NN	O
for  	for  	 IN	O
analysis  	analysis  	 NN	O
of  	of  	 IN	O
RANTES  	RANTES  	 NNP	B-NP
proteoforms 	proteoforms 	 NN	I-NP
.  	.  	 .	O
RANTES  	RANTES  	 NNP	B-NP
MSIA  	MSIA  	 NNP	I-NP
can  	can  	 MD	O
detect  	detect  	 VB	O
and  	and  	 CC	O
analyze  	analyze  	 VB	O
RANTES  	RANTES  	 JJ	B-NP
proteoforms  	proteoforms  	 NN	I-NP
and  	and  	 CC	O
provide  	provide  	 VB	O
an  	an  	 DT	O
insight  	insight  	 NN	O
into  	into  	 IN	O
the  	the  	 DT	O
endogenous  	endogenous  	 JJ	B-NP
protein  	protein  	 NN	I-NP
modifications 	modifications 	 NNS	I-NP
.  	.  	 .	O
